HONG KONG, Jan. 31, 2026 /PRNewswire/ — The Compilation of Classics in the Flourishing Age: Exhibition of Achievements in Compiling A Comprehensive Collection of Ancient Chinese Paintings is on display at the City University of Hong Kong (CityUHK) from January 15 to February 6. The exhibition is presented through an institutional collaboration led by the […]
Category Archives: Pr Newswire
SHANGHAI, Jan. 31, 2026 /PRNewswire/ — Amid the surging wave of innovation in China’s biopharmaceutical industry, a decade is long enough to witness the full evolution of a sector—from its initial emergence and growth to fundamental transformation. In 2015, as regulatory reform ignited local innovation, Lang Guojun, after earning his PhD from Zhejiang University and […]
Celebrating a new year filled with endless fun MACAO, Jan. 31, 2026 /PRNewswire/ — As the Year of the Horse approaches, the city is alive with the vibrant energy of the season. To celebrate Chinese New Year, SJM Resorts, S.A. (“SJM”) presents an exciting, and joy-filled festive journey across its hotels, resort, and food hall from […]
SAN FRANCISCO, Jan. 31, 2026 /PRNewswire/ — Dreame Robotic Vacuum hosted its launch event, The Age of Dreame Intelligence, in the heart of Silicon Valley’s Stanford area, a premier global hub for technological innovation. Dreame Robotic Vacuum officially announced that it has secured the top market share in 30 countries and regions as of 2025. The event […]
LONDON, Jan. 31, 2026 /PRNewswire/ — Statement from the Defence, Security and Resilience Bank (DSRB) Development Group: The DSRB Development Group welcomes the statement by Canada’s Minister of Finance confirming Canada’s leading role with regards the establishment of the Defence, Security and Resilience Bank. Canada’s leadership reflects a shared understanding among allies that strengthening defence […]
Pr Newswire
Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles
31
Jan
Jan
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment LOS ANGELES, Jan. 30, 2026 (GLOBE NEWSWIRE) — As part of Grammy Week in Los Angeles, Oxford Healthspan will offer a preview of its new Primeadine® GF Powder on February 1, through a custom Primeadine Longevity Shot, served during an invite-only celebration of artists and […]
Pr Newswire
Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger
31
Jan
Jan
CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) — Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”), today announced that it has commenced an exchange offer (the “Offer”) involving its Series C Non-Convertible Redeemable Preferred Stock (the “Series C Preferred Stock”) identified in the Prospectus/Consent Solicitation/Offer to Exchange (as defined below) in connection with Enzon’s […]
Pr Newswire
Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
31
Jan
Jan
MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) — Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025 after market close on Wednesday, February 25, 2026 at approximately 4:30 p.m. Eastern Time. The Company will […]
31
Jan
Jan
WALTHAM, Mass., Jan. 30, 2026 (GLOBE NEWSWIRE) — Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that its independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 117,339 […]
31
Jan
Jan
SEATTLE and VANCOUVER, British Columbia, Jan. 30, 2026 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced that effective January 28, 2026, Achieve’s board of directors approved stock option grants to purchase an […]